Dubin-Johnson syndrome synonyms

Dubin-Johnson syndrome is a rare, benign, autosomal recessive disorder characterized by chronic conjugated hyperbilirubinemia. It is most commonly referred to by its eponymous name, though it is also historically and clinically documented as Chronic Idiopathic Jaundice or Black Liver Jaundice due to the characteristic pigmentation of the liver.

What are the common synonyms and historical names for Dubin-Johnson syndrome?

When reviewing medical literature, you may encounter several terms used to describe Dubin-Johnson syndrome. The condition was independently described in 1954 by Frank Dubin and Frank Johnson, as well as by Isaac Sprinz and Richard Nelson. Consequently, you might occasionally see it referred to as Dubin-Johnson-Sprinz syndrome in older or specialized texts. Because the condition causes a distinct dark appearance of the liver tissue, it has historically been called Black Liver Jaundice. Other terms found in legacy medical records include Chronic Idiopathic Jaundice and Hyperbilirubinemia Type II. While these terms describe the same clinical entity, Dubin-Johnson syndrome remains the standard nomenclature used by modern clinicians worldwide.

How is the condition classified in major medical databases?

To ensure consistency in electronic health records and clinical research, international medical organizations assign specific codes to Dubin-Johnson syndrome. These identifiers help medical professionals track the condition accurately across different healthcare systems:

• Orphanet: ORPHA276


• OMIM (Online Mendelian Inheritance in Man): #237500


• ICD-10 (International Classification of Diseases): E80.6 (Other disorders of bilirubin metabolism)


• ICD-11: 5C50.2 (Dubin-Johnson syndrome)

Why does Dubin-Johnson syndrome have multiple names?

The existence of multiple names for Dubin-Johnson syndrome is primarily a result of the way medicine evolved during the mid-20th century. Before genetic testing was available, many rare metabolic conditions were named after the physicians who first characterized the clinical presentation. Furthermore, because the disease is characterized by a buildup of bilirubin—which leads to jaundice—early researchers often named the condition based on the visible symptoms (jaundice) rather than the underlying molecular cause, which is a mutation in the ABCC2 gene. This gene mutation disrupts the transport of conjugated bilirubin out of the liver cells, leading to the condition known as Dubin-Johnson syndrome.

Which name is preferred by medical professionals today?

In contemporary clinical practice, Dubin-Johnson syndrome is the preferred and universally recognized term. Using the eponymous name ensures clear communication between specialists, such as hepatologists and geneticists, and helps patients navigate reliable resources like DiseaseMaps.org. While terms like "Black Liver Jaundice" are medically accurate descriptions of the pathology, they are considered colloquial and are rarely used in formal diagnostic reports today.

Next steps

• Consult with a board-certified hepatologist or gastroenterologist to confirm your diagnosis through specific liver function tests or genetic screening.


• Request your medical records using the ICD-10 or ICD-11 codes provided above to ensure accuracy across healthcare providers.


• Connect with the community at DiseaseMaps.org to share experiences with others living with Dubin-Johnson syndrome.


• Ask your physician about genetic counseling if you are planning to start a family, as the condition follows an autosomal recessive inheritance pattern.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Dubin-Johnson syndrome (ORPHA276).


• NIH Genetic and Rare Diseases (GARD) Information Center: Dubin-Johnson syndrome.


• OMIM: Dubin-Johnson syndrome (#237500).


• World Health Organization: ICD-11 for Mortality and Morbidity Statistics (5C50.2).